Hepatotoxicity Seminar Series: Genetic Architecture of DILI in the Polygenic Risk Score Era

Date : Thursday, December 11, 11:00 am - 12:00 pm (EST)

While key HLA alleles (e.g., HLA-B*57:01, HLA-A*33:01, HLA-DRB1*15:01) are known contributors to drug-specific DILI, their low positive predictive value limits clinical implementation. Join the Hepatotoxicity SIG as they explore emerging evidence from recent genome-wide association studies. This session offers timely insights into the evolving landscape of DILI risk assessment.